Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14-Reference-Cited by-同舟云学术

Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14

Published:2018-08 Issue: Volume:68-69 Page:474-489
ISSN:0945-053X
Container-title:Matrix Biology
language:en
Short-container-title:Matrix Biology

Author:

Regős Eszter,Abdelfattah Hadeer Hesham,Reszegi Andrea,Szilák László,Werling Klára,Szabó Gábor,Kiss András,Schaff Zsuzsa,Kovalszky Ilona^ORCID,Baghy Kornélia

Funder

Hungarian National Research Fund

EU H2020 MSCA-RISE

Publisher

Elsevier BV

Subject

Molecular Biology

Reference48 articles.

1. Liver cirrhosis;Schuppan;Lancet,2008

2. Reversibility of hepatic fibrosis;van der Meer;Ned. Tijdschr. Geneeskd.,2014

3. Development and regression of cirrhosis;Saffioti;Dig. Dis.,2016

4. Inactivation of myofibroblasts during regression of liver fibrosis;Kisseleva;Cell Cycle,2013

5. Liver fibrosis and extracellular matrix;Biagini;J. Hepatol.,1989

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Serum Proteins Suggest Inflammation, Fibrogenesis and Angiogenesis in Adult Patients with a Fontan Circulation;International Journal of Molecular Sciences;2024-05-16

2. Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway;Discovery Medicine;2024

3. Integrated Bioinformatic Analysis of Differentially Expressed Genes Associated with Wound Healing;CELL J;2023

4. Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases;Current Drug Targets;2023-11

5. Redefining metalloproteases specificity through network proteolysis;Trends in Molecular Medicine;2023-11